US6323071042 - NTRA - A14VPJ (XNAS)
NATERA INC Aktie
127,13 USD
Aktuelle Kurse von NATERA INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung | Tagesveränderung % |
---|---|---|---|---|---|---|
NASDAQ |
NTRA
|
USD
|
19.09.2024 23:02
|
127,13 USD
| 127,10 USD | 0,02 % |
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,00 % | 0,49 % | 4,59 % | 17,72 % | 39,31 % | 151,59 % | 279,49 % |
Firmenprofil zu NATERA INC Aktie
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to identify chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that enables laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is based in Austin, Texas.
Unternehmensdaten zur NATERA INC Aktie
Name NATERA INC
Firma Natera, Inc.
Symbol NTRA
Website https://www.natera.com
Heimatbörse
NASDAQ
WKN A14VPJ
ISIN US6323071042
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Diagnostics & Research
CEO Mr. Steven Leonard Chapman
Marktkapitalisierung 14 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 3,3 T
Adresse 13011 McCallen Pass Building A, 78753 San Carlos
IPO Datum 2015-07-01
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | NTRA |
Weitere Aktien
Investoren die NATERA INC halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024